NCT00319020View on ClinicalTrials.gov

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 23, 2005

Primary Completion Date

October 28, 2011

Study Completion Date

October 28, 2011

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Bosentan

32-mg dispersible and breakable tablet. The body weight-adjusted dose of the dispersible tablet was dispersed in a teaspoon of water (not mixed with food) before being administered orally